Down-regulation of toll-like receptor 4 alleviates intestinal ischemia reperfusion injury and acute lung injury in mice

Oncotarget

Volumn 8, Issue 8, 2017, Pages 13678-13689

  Zhu, Qiankun ^a   He, Guizhen ^a   Wang, Jie ^a   Wang, Yukang ^a   Chen, Wei ^a   Guo, Tai ^b  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^b NATIONAL INSTITUTE FOR THE CONTROL OF PHARMACEUTICAL AND BIOLOGICAL PRODUCTS   (China)

Author keywords

Acute lung injury (ALI); Inflammatory response; Intestinal ischemia reperfusion (IR); Oxidative stress; Toll like receptor 4 (TLR4)

Indexed keywords

ALANINE AMINOTRANSFERASE; CASPASE 3; CREATININE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 2; MONOCYTE CHEMOTACTIC PROTEIN 1; NITRIC OXIDE; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR; TLR4 PROTEIN, MOUSE;

ACUTE LUNG INJURY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; HISTOPATHOLOGY; INFLAMMATION; INTESTINE INJURY; MOUSE; MUTANT; NONHUMAN; OXIDATIVE STRESS; REPERFUSION INJURY; SURVIVAL RATE; WILD TYPE; ANIMAL; C57BL MOUSE; GENETICS; INTESTINE; INTESTINE MUCOSA; MALE; METABOLISM; PATHOLOGY; PHYSIOLOGY; VASCULARIZATION;

ACUTE LUNG INJURY; ANIMALS; DOWN-REGULATION; INFLAMMATION; INTESTINAL MUCOSA; INTESTINES; MALE; MICE; MICE, INBRED C57BL; OXIDATIVE STRESS; REPERFUSION INJURY; TOLL-LIKE RECEPTOR 4;

EID: 85013371820     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.14624     Document Type: Article

References (45)

1. Chen LW, Egan L, Li ZW, Greten FR, Kagnoff MF, Karin M. The two faces of IKK and NF-kappaB inhibition: prevention of systemic inflammation but increased local injury following intestinal ischemia-reperfusion. Nat Med. 2003; 9:575-581
2. Zhi-Yong S, Dong YL, Wang XH. Bacterial translocation and multiple system organ failure in bowel ischemia and reperfusion. J Trauma. 1992; 32:148-153
3. Jensen TH, Heslet L, Fomsgaard A. Translocation and multiple organ failure. [Article in Danish]. Ugeskr Laeger. 1993; 155:2861-2866
4. Lane JS, Todd KE, Lewis MP, Gloor B, Ashley SW, Reber HA, McFadden DW, Chandler CF. Interleukin-10 reduces the systemic inflammatory response in a murine model of intestinal ischemia/reperfusion. Surgery. 1997; 122:288-294
5. Schmeling DJ, Caty MG, Oldham KT, Guice KS, Hinshaw DB. Evidence for neutrophil-related acute lung injury after intestinal ischemia-reperfusion. Surgery. 1989; 106:195-201, 201-202
6. Montero MF, Saurim R, Bonservizi WG, Koike MK, Taha MO. Heart injury following intestinal ischemia reperfusion in rats is attenuated by association of ischemic preconditioning and adenosine. Acta Cir Bras. 2014; 29:67-71
7. Aldemir D, Tecder-Unal M, Tufan H, Ogus E, Turkoglu S, Kayhan Z. Effect of intestinal ischemia-reperfusion on rat kidney. Transplant Proc. 2002; 34:2023-2026
8. Poggetti RS, Moore EE, Moore FA, Koike K, Banerjee A. Gut ischemia/reperfusion-induced liver dysfunction occurs despite sustained oxygen consumption. J Surg Res. 1992; 52:436-442
9. Rubenfeld GD, Caldwell E, Peabody E, Weaver J, Martin DP, Neff M, Stern EJ, Hudson LD. Incidence and outcomes of acute lung injury. N Engl J Med. 2005; 353:1685-1693
10. Wheeler AP, Bernard GR. Acute lung injury and the acute respiratory distress syndrome: a clinical review. Lancet. 2007; 369:1553-1564
11. Matuschak GM, Lechner AJ. Acute lung injury and the acute respiratory distress syndrome: pathophysiology and treatment. Mo Med. 2010; 107:252-258
12. Roberts AM. Central role of oxidative stress and its signaling pathways in causing and preventing acute lung injury. Crit Care Med. 2011; 39:2776-2777
13. Lagan AL, Melley DD, Evans TW, Quinlan GJ. Pathogenesis of the systemic inflammatory syndrome and acute lung injury: role of iron mobilization and decompartmentalization. Am J Physiol Lung Cell Mol Physiol. 2008; 294:L161-L174
14. Tavaf-Motamen H, Miner TJ, Starnes BW, Shea-Donohue T. Nitric oxide mediates acute lung injury by modulation of inflammation. J Surg Res. 1998; 78:137-142
15. Madl AK, Plummer LE, Carosino C, Pinkerton KE. Nanoparticles, lung injury, and the role of oxidant stress. Annu Rev Physiol. 2014; 76:447-465
16. Vasileiou I, Kostopanagiotou G, Katsargyris A, Klonaris C, Perrea D, Theocharis S. Toll-like receptors: a novel target for therapeutic intervention in intestinal and hepatic ischemia-reperfusion injury? Expert Opin Ther Targets. 2010; 14:839-853
17. Arumugam TV, Okun E, Tang SC, Thundyil J, Taylor SM, Woodruff TM. Toll-like receptors in ischemia-reperfusion injury. Shock. 2009; 32:4-16
18. Watson MJ, Ke B, Shen XD, Gao F, Busuttil RW, Kupiec-Weglinski JW, Farmer DG. Intestinal ischemia/reperfusion injury triggers activation of innate toll-like receptor 4 and adaptive chemokine programs. Transplant Proc. 2008; 40:3339-3341
19. Wei SC, Rosenberg IM, Cao Z, Huett AS, Xavier RJ, Podolsky DK. Tribbles 2 (Trib2) is a novel regulator of toll-like receptor 5 signaling. Inflamm Bowel Dis. 2012; 18:877-888
20. Singh JC, Cruickshank SM, Newton DJ, Wakenshaw L, Graham A, Lan J, Lodge JP, Felsburg PJ, Carding SR. Toll-like receptor-mediated responses of primary intestinal epithelial cells during the development of colitis. Am J Physiol Gastrointest Liver Physiol. 2005; 288:G514-G524
21. Nace GW, Huang H, Klune JR, Eid RE, Rosborough BR, Korff S, Li S, Shapiro RA, Stolz DB, Sodhi CP, Hackam DJ, Geller DA, Billiar TR, et al. Cellular-specific role of tolllike receptor 4 in hepatic ischemia-reperfusion injury in mice. Hepatology. 2013; 58:374-387
22. Bell MT, Puskas F, Agoston VA, Cleveland JJ, Freeman KA, Gamboni F, Herson PS, Meng X, Smith PD, Weyant MJ, Fullerton DA, Reece TB. Toll-like receptor 4-dependent microglial activation mediates spinal cord ischemiareperfusion injury. Circulation. 2013; 128:S152-S156
23. Hua F, Tang H, Wang J, Prunty MC, Hua X, Sayeed I, Stein DG. TAK-242, an antagonist for Toll-like receptor 4, protects against acute cerebral ischemia/reperfusion injury in mice. J Cereb Blood Flow Metab. 2015; 35:536-542
24. Reino DC, Palange D, Feketeova E, Bonitz RP, Xu DZ, Lu Q, Sheth SU, Pena G, Ulloa L, De Maio A, Feinman R, Deitch EA. Activation of toll-like receptor 4 is necessary for trauma hemorrhagic shock-induced gut injury and polymorphonuclear neutrophil priming. Shock. 2012; 38:107-114
25. Sweeney RM, McAuley DF. Acute respiratory distress syndrome. Lancet. 2016; 388:2416-2430
26. Deitch EA. Multiple organ failure. Pathophysiology and potential future therapy. Ann Surg. 1992; 216:117-134
27. Hagar JA, Powell DA, Aachoui Y, Ernst RK, Miao EA. Cytoplasmic LPS activates caspase-11: implications in TLR4-independent endotoxic shock. Science. 2013; 341:1250-1253
28. Tatum PJ, Harmon CM, Lorenz RG, Dimmitt RA. Tolllike receptor 4 is protective against neonatal murine ischemia-reperfusion intestinal injury. J Pediatr Surg. 2010; 45:1246-1255
29. Ben DF, Yu XY, Ji GY, Zheng DY, Lv KY, Ma B, Xia ZF. TLR4 mediates lung injury and inflammation in intestinal ischemia-reperfusion. J Surg Res. 2012; 174:326-333
30. Molmenti EP, Ziambaras T, Perlmutter DH. Evidence for an acute phase response in human intestinal epithelial cells. J Biol Chem. 1993; 268:14116-14124
31. Bauer TT, Monton C, Torres A, Cabello H, Fillela X, Maldonado A, Nicolas JM, Zavala E. Comparison of systemic cytokine levels in patients with acute respiratory distress syndrome, severe pneumonia, and controls. Thorax. 2000; 55:46-52
32. Ren W, Wang Z, Hua F, Zhu L. Plasminogen activator inhibitor-1 regulates LPS-induced TLR4/MD-2 pathway activation and inflammation in alveolar macrophages. Inflammation. 2015; 38:384-393
33. Enkhbaatar P, Wang J, Saunders F, Lange M, Hamahata A, Rehberg S, Parkinson JF, Traber LD, Herndon DN, Traber DL. Mechanistic aspects of inducible nitric oxide synthase-induced lung injury in burn trauma. Burns. 2011; 37:638-645
34. Chen TH, Liao FT, Yang YC, Wang JJ. Inhibition of inducible nitric oxide synthase ameliorates myocardial ischemia/reperfusion injury-induced acute renal injury. Transplant Proc. 2014; 46:1123-1126
35. Cao W, Li M, Li J, Li C, Xu X, Gu W. Geranylgeranylacetone ameliorates lung ischemia/reperfusion injury by HSP70 and thioredoxin redox system: NF-kB pathway involved. Pulm Pharmacol Ther. 2015; 32:109-115
36. Jing H, Shen G, Wang G, Zhang F, Li Y, Luo F, Yao J, Tian XF. MG132 alleviates liver injury induced by intestinal ischemia/reperfusion in rats: involvement of the AhR and NFkappaB pathways. J Surg Res. 2012; 176:63-73
37. Li L, Miao X, Ni R, Miao X, Wang L, Gu X, Yan L, Tang Q, Zhang D. Epithelial-specific ETS-1 (ESE1/ELF3) regulates apoptosis of intestinal epithelial cells in ulcerative colitis via accelerating NF-kappaB activation. Immunol Res. 2015; 62:198-212
38. Li Y, Cao Y, Zeng Z, Liang M, Xue Y, Xi C, Zhou M, Jiang W. Angiotensin-converting enzyme 2/angiotensin-(1-7)/Mas axis prevents lipopolysaccharide-induced apoptosis of pulmonary microvascular endothelial cells by inhibiting JNK/NF-kappaB pathways. Sci Rep. 2015; 5:8209
39. Moore FA, Moore EE, Poggetti R, McAnena OJ, Peterson VM, Abernathy CM, Parsons PE. Gut bacterial translocation via the portal vein: a clinical perspective with major torso trauma. J Trauma. 1991; 31:629-636, 636-638
40. Reino DC, Pisarenko V, Palange D, Doucet D, Bonitz RP, Lu Q, Colorado I, Sheth SU, Chandler B, Kannan KB, Ramanathan M, Xu DZ, Deitch EA, et al. Trauma hemorrhagic shock-induced lung injury involves a gut-lymphinduced TLR4 pathway in mice. Plos One. 2011; 6:e14829
41. Basso FG, Pansani TN, Turrioni AP, Soares DG, de Souza CC, Hebling J. Tumor Necrosis Factor-Alpha and Interleukins Il-1beta, Il-6, and Il-8 Impair in Vitro Migration and Induce Apoptosis of Gingival Fibroblasts and Epithelial Cells, Delaying Wound Healing. J Periodontol. 2016; 8:990-996
42. Fan JH, Feng GG, Huang L, Tang GD, Jiang HX, Xu J. Naofen promotes TNF-alpha-mediated apoptosis of hepatocytes by activating caspase-3 in lipopolysaccharidetreated rats. World J Gastroenterol. 2014; 20:4963-4971
43. Moine P, McIntyre R, Schwartz MD, Kaneko D, Shenkar R, Le Tulzo Y, Moore EE, Abraham E. NF-kappaB regulatory mechanisms in alveolar macrophages from patients with acute respiratory distress syndrome. Shock. 2000; 13:85-91
44. Schwartz MD, Moore EE, Moore FA, Shenkar R, Moine P, Haenel JB, Abraham E. Nuclear factor-kappa B is activated in alveolar macrophages from patients with acute respiratory distress syndrome. Crit Care Med. 1996; 24:1285-1292
45. Chiu CJ, McArdle AH, Brown R, Scott HJ, Gurd FN. Intestinal mucosal lesion in low-flow states. I. A morphological, hemodynamic, and metabolic reappraisal. Arch Surg. 1970; 101:478-483